131 related articles for article (PubMed ID: 37137831)
21. Transient Severe Respiratory Motion Artifacts After Application of Gadoxetate Disodium: What We Currently Know.
Well L; Weinrich JM; Adam G; Bannas P
Rofo; 2018 Jan; 190(1):20-30. PubMed ID: 29156475
[TBL] [Abstract][Full Text] [Related]
22. Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis.
Di Martino M; Marin D; Guerrisi A; Baski M; Galati F; Rossi M; Brozzetti S; Masciangelo R; Passariello R; Catalano C
Radiology; 2010 Sep; 256(3):806-16. PubMed ID: 20720069
[TBL] [Abstract][Full Text] [Related]
23. Liver Imaging Reporting and Data System (LI-RADS) v2018: diagnostic value of ancillary features favoring malignancy in hypervascular observations ≥ 10 mm at intermediate (LR-3) and high probability (LR-4) for hepatocellular carcinoma.
Cannella R; Vernuccio F; Sagreiya H; Choudhury KR; Iranpour N; Marin D; Furlan A
Eur Radiol; 2020 Jul; 30(7):3770-3781. PubMed ID: 32107603
[TBL] [Abstract][Full Text] [Related]
24. Comparison of gadoxetate disodium-enhanced MRI sequences for measuring hepatic observation size and its implication of LI-RADS classification.
Choi JY; Ha J; Choi SH; Kang HJ; Kim SY; Kim KW
Abdom Radiol (NY); 2022 Mar; 47(3):1024-1031. PubMed ID: 35020008
[TBL] [Abstract][Full Text] [Related]
25. Respiratory-motion artefacts in liver MRI following injection of gadoxetate disodium and gadobenate dimeglumine: an intra-individual comparative study in cirrhotic patients.
Furlan A; Close ON; Borhani AA; Wu YH; Heller MT
Clin Radiol; 2017 Jan; 72(1):93.e1-93.e6. PubMed ID: 27633725
[TBL] [Abstract][Full Text] [Related]
26. The role of enhancing capsule and modified capsule appearances in LI-RADS for diagnosing HCC ≤ 3.0 cm on gadoxetate disodium-enhanced MRI.
Pan J; Song M; Yang L; Zhao Y; Zhu Y; Wang M; Chen F
Eur Radiol; 2023 Aug; 33(8):5801-5811. PubMed ID: 36894754
[TBL] [Abstract][Full Text] [Related]
27. Optimal Combination of Features on Gadoxetate Disodium-enhanced MR Imaging for Non-invasive Differential Diagnosis of Hepatocellular Carcinoma: The JAMP-HCC Study.
Ichikawa S; Motosugi U; Morisaka H; Kozaka K; Goshima S; Ichikawa T
Magn Reson Med Sci; 2021 Mar; 20(1):47-59. PubMed ID: 32101818
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features.
Jiang H; Song B; Qin Y; Chen J; Xiao D; Ha HI; Liu X; Oloruntoba-Sanders O; Erkanli A; Muir AJ; Bashir MR
Eur Radiol; 2021 Jun; 31(6):3638-3648. PubMed ID: 33245494
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the diagnostic performance of imaging criteria for HCCs ≤ 3.0 cm on gadoxetate disodium-enhanced MRI.
Byun J; Choi SH; Byun JH; Lee SJ; Kim SY; Won HJ; Shin YM; Kim PN
Hepatol Int; 2020 Jul; 14(4):534-543. PubMed ID: 32314171
[TBL] [Abstract][Full Text] [Related]
31. Transient severe motion in the arterial phase during gadoxetate disodium-enhanced MR imaging: evaluation of patients with multiple MR examinations.
Im WH; Song JS; Park EH; Kwak HS
Abdom Radiol (NY); 2017 Oct; 42(10):2393-2401. PubMed ID: 28396919
[TBL] [Abstract][Full Text] [Related]
32. Value of threshold growth as a major diagnostic feature of hepatocellular carcinoma in LI-RADS.
Choi SJ; Choi SH; Kim DW; Kwag M; Byun JH; Won HJ; Shin YM
J Hepatol; 2023 Mar; 78(3):596-603. PubMed ID: 36402451
[TBL] [Abstract][Full Text] [Related]
33. New strategy for Liver Imaging Reporting and Data System category M to improve diagnostic performance of MRI for hepatocellular carcinoma ≤ 3.0 cm.
Jang JK; Choi SH; Byun JH; Park SY; Lee SJ; Kim SY; Won HJ; Shin YM; Kim PN
Abdom Radiol (NY); 2022 Jul; 47(7):2289-2298. PubMed ID: 35523888
[TBL] [Abstract][Full Text] [Related]
34. Influence of Gadoxetate Disodium on Oxygen Saturation and Heart Rate during Dynamic Contrast-enhanced MR Imaging.
Hayashi T; Saitoh S; Tsuji Y; Takahashi J; Tagaya N; Hiramoto M; Fukuzawa K; Tano M; Miyati T; Kumada H
Radiology; 2015 Sep; 276(3):756-65. PubMed ID: 25811243
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic Performance of 2018 KLCA-NCC Practice Guideline for Hepatocellular Carcinoma on Gadoxetic Acid-Enhanced MRI in Patients with Chronic Hepatitis B or Cirrhosis: Comparison with LI-RADS Version 2018.
Lee SM; Lee JM; Ahn SJ; Kang HJ; Yang HK; Yoon JH
Korean J Radiol; 2021 Jul; 22(7):1066-1076. PubMed ID: 33739633
[TBL] [Abstract][Full Text] [Related]
36. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
37. Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis.
Vidili G; Arru M; Solinas G; Calvisi DF; Meloni P; Sauchella A; Turilli D; Fabio C; Cossu A; Madeddu G; Babudieri S; Zocco MA; Iannetti G; Di Lembo E; Delitala AP; Manetti R
World J Gastroenterol; 2022 Jul; 28(27):3488-3502. PubMed ID: 36158272
[TBL] [Abstract][Full Text] [Related]
38. Prospective evaluation of Gadoxetate-enhanced magnetic resonance imaging and computed tomography for hepatocellular carcinoma detection and transplant eligibility assessment with explant histopathology correlation.
Jhaveri KS; Babaei Jandaghi A; Bhayana R; Elbanna KY; Espin-Garcia O; Fischer SE; Ghanekar A; Sapisochin G
Cancer Imaging; 2023 Feb; 23(1):22. PubMed ID: 36841796
[TBL] [Abstract][Full Text] [Related]
39. Gadoxetate disodium-related event during image acquisition: a prospective multi-institutional study for better MR practice.
Kromrey ML; Hori M; Goshima S; Kozaka K; Hyodo T; Nakamura Y; Nishie A; Tamada T; Shimizu T; Kanki A; Motosugi U
Eur Radiol; 2020 Jan; 30(1):281-290. PubMed ID: 31338655
[TBL] [Abstract][Full Text] [Related]
40. Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium: examination recovery with a multiple arterial phase acquisition.
Pietryga JA; Burke LM; Marin D; Jaffe TA; Bashir MR
Radiology; 2014 May; 271(2):426-34. PubMed ID: 24475864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]